相关实验视频
Updated: Jul 16, 2026

08:32
Extraction of Tissue Antigens for Functional Assays
Published on: September 10, 2012
免疫学:在1型糖尿病中胰岛素自身抗原性
1Torrey Pines Institute for Molecular Studies, San Diego, California 92121-1122, USA. dbwilson@tpims.org
Nature
|November 25, 2005
概括
胰岛素可以通过触发T细胞反应来启动自身免疫1型糖尿病. 然而,不典型的T细胞对胰岛素片段的反应挑战了这种自身免疫糖尿病假设,影响了预防和治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 自免疫性疾病 自免疫性疾病
背景情况:
- 1型糖尿病是由胰腺β岛细胞的自身免疫破坏引起的,导致胰岛素缺乏和高血糖症.
- 甲状腺衍生的淋巴细胞 (T细胞) 参与了1型糖尿病的发病,但尚未完全理解启动自身抗原的原因.
研究的目的:
- 研究胰岛素作为主要的自身抗原,在小鼠和人类中引发自发的1型糖尿病.
- 评估胰岛素作为自身抗原对1型糖尿病预防和治疗的影响.
主要方法:
- 在自身免疫糖尿病的背景下分析对胰岛素及其碎片的T细胞反应.
- 在小鼠模型中发现的结果的比较研究 (Nakayama等人). 和人类研究 (肯特等人. ) 的情况.
主要成果:
- 纳卡亚马和其他人. 和肯特等人. 建议胰岛素作为1型糖尿病发病的主要自身抗原,分别在小鼠和人类中使用.
- 肯特和其他人. 描述非典型的T细胞对人体胰岛素片段的反应,可能挑战胰岛素的拟议作用.
结论:
- 胰岛素是1型糖尿病的主要自身抗原的假设需要进一步调查,因为观察到非典型的T细胞反应.
- 澄清胰岛素及其碎片在T细胞激活中的作用对于开发有效的1型糖尿病预防和治疗策略至关重要.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

